The National Agency for Health of the Republic of Moldova in Georgia from Europe region had released this tender for Treatment of patients with rare diseases and subject to permanent replacement therapy (27 03 03 06) with tender notice no. NAT260008581 published on 28 Apr 2026. The tender expired on 24 May 2026. This tender is sourced from Georgia Tenders and is eligible for suppliers interested in General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Antineoplastic and immunomodulating agents, Other therapeutic products, Addiction treatment. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 12632883.
*The deadline for this tender has passed.
Tender Notice No:
NAT260008581
Tender Organisation:
National Agency for Health of the Republic of Moldova
Tender Sector:
Tender Service:
Worldwide
Tender Region:
Tender Country:
Tender CPV:
33650000 : General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33652000 : Antineoplastic and immunomodulating agents
33693000 : Other therapeutic products
33693300 : Addiction treatment
Tender Source:
Georgia Tenders
Tender Document Type:
Tender Notice
Tender Description:
Treatment of patients with rare diseases and subject to permanent replacement therapy (27 03 03 06)
Tender Bidding Type:
Tender Document:
Looking for more tenders like this one in General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Antineoplastic and immunomodulating agents, Other therapeutic products, Addiction treatment? With over 11 million global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Healthcare & Medical sector in Georgia, or expanding across regions, we provide live, accurate, and relevant updates every day.
Our platform sources tenders from:
Every day, we add hundreds of new RFPs, RFQs, EOIs, and contract awards across multiple sectors and geographies. This tender from Georgia is just a sample of what's available right now.
Tender Impulse covers:
Each listing is categorized using CPV codes like 33650000, 33652000, 33693000, 33693300, enabling precise filtering. Search by:
While you're viewing a tender in Georgia, Tender Impulse offers access to tenders across:
Tender Impulse provides more than listings:
Thousands of new tenders are added daily-across countries, sectors, and CPV codes. With Tender Impulse, you gain strategic insight, timely alerts, and a competitive edge.
Request a free live demo now to unlock tenders customized to your Healthcare & Medical, Georgia, and General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Antineoplastic and immunomodulating agents, Other therapeutic products, Addiction treatment categories.
The tender has been issued by National Agency for Health of the Republic of Moldova in Georgia. Such a type of tender falls under General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Antineoplastic and immunomodulating agents, Other therapeutic products, Addiction treatment, within the Healthcare & Medical Tenders sector, and is listed on Tender Impulse under notice number NAT260008581.
The notice was published on 28 Apr 2026 and submissions close on 24 May 2026. Late bids are rarely accepted in public procurement, so aim to have your documents ready several days before the closing date.
It is classified under CPV codes 33650000, 33652000, 33693000, 33693300, which correspond to General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Antineoplastic and immunomodulating agents, Other therapeutic products, Addiction treatment. If your company supplies these products or services, these are the codes to save in your alert profile so no matching tender passes you by.
No - and this matters. Tender Impulse is a tender aggregation and alert service: we collect procurement notices from official sources around the world and list them in one place. We do not receive, forward or evaluate bids. Your bid for this tender must be submitted directly to National Agency for Health of the Republic of Moldova, using the method described in the original tender document, before 24 May 2026. Tender Impulse provides complete assistance in submitting all bids posted on its website.
Request a live demo on Tender Impulse and our tender experts will walk you through this listing, share the available documents, and explain how to submit your bid to National Agency for Health of the Republic of Moldova. Subscribers also receive help with registration requirements and, where needed, translation of non-English notices - but the submission itself always goes from you to the buyer.
There are currently 621 live tenders of 56422 total tenders from Georgia on Tender Impulse. You can browse them on our Georgia tenders page, or save a search combining Georgia with CPV codes {full_cpv_codes} - we will then email you every new match on the day it is published.
Suppliers must verify technical specifications, the delivery schedules and any other intrinsic details as provided in the complete bid documents before deciding to submit their bids. All necessary certifications and supplier registrations must be undertaken before participation.
The procurement is applicable to companies in the General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Antineoplastic and immunomodulating agents, Other therapeutic products, Addiction treatment and related industries. If you belong to this industry, you can review the technical documents before assessing your relevance to your company.
The public procurement trends for Treatment of patients with rare diseases and subject to permanent replacement therapy (27 03 03 06) can be assessed by viewing historical data and buying patterns for this product. Subscribed members can view and even download reports of tenders released in the past for their market research. This shall allow them to carefully prepare a compelling bid.
Your action completed successfully.